Detalhe da pesquisa
1.
Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma.
BMC Nephrol
; 19(1): 178, 2018 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30012107
2.
Increased fracture risk in plasma cell dyscrasias is associated with poorer overall survival.
Br J Haematol
; 179(1): 61-65, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28653323
3.
Multiple myeloma can be accurately diagnosed in acute kidney injury patients using a rapid serum free light chain test.
BMC Nephrol
; 18(1): 247, 2017 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28728609
4.
Serum tryptase concentration and progression to end-stage renal disease.
Eur J Clin Invest
; 46(5): 460-74, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26999448
5.
Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury.
Eur J Haematol
; 96(6): 610-7, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26248588
6.
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease.
Kidney Int
; 87(4): 692-7, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25296094
7.
A population-based study of the impact of dialysis on mortality in multiple myeloma.
Br J Haematol
; 180(4): 588-591, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27766629
8.
Serum free light chain level at diagnosis in myeloma cast nephropathy-a multicentre study.
Blood Cancer J
; 10(3): 28, 2020 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32127527
9.
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease.
PLoS One
; 13(5): e0197043, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29742142
10.
Current Trends of Renal Impairment in Multiple Myeloma.
Kidney Dis (Basel)
; 1(4): 241-57, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27536684
11.
Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study.
PLoS One
; 11(11): e0165675, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27832126
12.
Allopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study.
PLoS One
; 9(3): e91961, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24632580
13.
Paricalcitol in secondary hyperparathyroidism and the survival benefit in patients with chronic kidney disease.
J Ren Care
; 37(2): 75-9, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21561542